91
92
93
95
Li, Ye, Kool, Clemens, Engelen, Peter-Jan
Veröffentlicht in: Li , Y , Kool , C & Engelen , P-J 2020 , ' Analyzing the Business Case for Hydrogen-Fuel Infrastructure Investments with Endogenous Demand in The Netherlands : A Real Options Approach ' , Sustainability , vol. 12 , no. 13 , 5424 . https://doi.org/10.3390/su12135424;
2020
Veröffentlicht in: Li , Y , Kool , C & Engelen , P-J 2020 , ' Analyzing the Business Case for Hydrogen-Fuel Infrastructure Investments with Endogenous Demand in The Netherlands : A Real Options Approach ' , Sustainability , vol. 12 , no. 13 , 5424 . https://doi.org/10.3390/su12135424;
2020
96
97
98
99
van der Velde, K Joeri, Singh, Gurnoor, Kaliyaperumal, Rajaram, Liao, XiaoFeng, de Ridder, Sander, Rebers, Susanne, Kerstens, Hindrik H D, de Andrade, Fernanda, van Reeuwijk, Jeroen, De Gruyter, Fini E, Hiltemann, Saskia, Ligtvoet, Maarten, Weiss, Marjan M, van Deutekom, Hanneke W M, Jansen, Anne M L, Stubbs, Andrew P, Vissers, Lisenka E L M, Laros, Jeroen F J, van Enckevort, Esther, Stemkens, Daphne, 't Hoen, Peter A C, Beliën, Jeroen A M, van Gijn, Mariëlle E, Swertz, Morris A
2022
2022
100
Ramos, Isaac Corro, Versteegh, Matthijs M., de Boer, Rudolf A., Koenders, Jolanda M. A., Linssen, Gerard C. M., Meeder, Joan G., Rutten-van Molken, Maureen P. M. H.
Veröffentlicht in: Ramos , I C , Versteegh , M M , de Boer , R A , Koenders , J M A , Linssen , G C M , Meeder , J G & Rutten-van Molken , M P M H 2017 , ' Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands : A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines ' , Value in Health , vol. 20 , no. 10 , pp. 1260-1269 . https://doi.org/10.1016/j.jval.2017.05.013;
2017
Veröffentlicht in: Ramos , I C , Versteegh , M M , de Boer , R A , Koenders , J M A , Linssen , G C M , Meeder , J G & Rutten-van Molken , M P M H 2017 , ' Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands : A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines ' , Value in Health , vol. 20 , no. 10 , pp. 1260-1269 . https://doi.org/10.1016/j.jval.2017.05.013;
2017